NADAC acquisition cost data for COMPRO 25 MG SUPPOSITORY. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00574722612 | $6.14 | 2022-12-21 | Rx |
| 00574722612 | $6.14 | 2022-12-21 | Rx |
Generic: Prochlorperazine | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $1.3M | 10,741 | 7,355 | $7.29 |
| 2020 | $1.3M | 9,567 | 6,421 | $7.72 |
| 2021 | $1.2M | 8,558 | 5,811 | $7.68 |
| 2022 | $1.1M | 8,159 | 5,511 | $7.43 |
| 2023 | $1.3M | 9,899 | 6,848 | $7.72 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $180.3K | 1,369 | 963 |
| Pennsylvania | $99.3K | 773 | 487 |
| New York | $91.8K | 700 | 493 |
| Florida | $73.3K | 454 | 332 |
| Michigan | $73.1K | 673 | 525 |
| Massachusetts | $68.4K | 480 | 277 |
| New Jersey | $65.8K | 463 | 345 |
| Missouri | $40.0K | 331 | 224 |
| Ohio | $36.2K | 250 | 157 |
| Washington | $36.0K | 352 | 224 |
| Texas | $34.1K | 245 | 202 |
| Oregon | $31.4K | 294 | 181 |
| North Carolina | $28.7K | 149 | 107 |
| Illinois | $28.0K | 237 | 176 |
| Alabama | $23.3K | 355 | 325 |
| Connecticut | $22.3K | 194 | 151 |
| Arizona | $21.8K | 156 | 117 |
| Georgia | $20.3K | 158 | 123 |
| Wisconsin | $20.0K | 162 | 106 |
| Minnesota | $19.6K | 191 | 149 |
| Colorado | $17.9K | 155 | 93 |
| Virginia | $16.7K | 143 | 93 |
| Indiana | $16.6K | 111 | 67 |
| Maryland | $16.3K | 142 | 106 |
| Kentucky | $13.8K | 77 | 43 |
| Tennessee | $13.7K | 97 | 66 |
| Maine | $12.5K | 101 | 73 |
| Oklahoma | $9.9K | 76 | 48 |
| Nebraska | $9.8K | 54 | 22 |
| Iowa | $9.8K | 73 | 41 |
| Rhode Island | $9.7K | 87 | 60 |
| South Carolina | $9.4K | 63 | 37 |
| Kansas | $9.2K | 58 | 49 |
| Arkansas | $9.0K | 55 | 36 |
| Louisiana | $8.8K | 70 | 55 |
| Idaho | $8.1K | 35 | 15 |
| New Hampshire | $8.0K | 64 | 49 |
| Nevada | $7.5K | 62 | 46 |
| New Mexico | $7.0K | 68 | 51 |
| Vermont | $6.4K | 43 | 28 |
| Montana | $6.3K | 48 | 20 |
| Hawaii | $4.2K | 28 | 15 |
| Mississippi | $4.0K | 34 | 20 |
| Utah | $3.9K | 30 | 20 |
| Delaware | $3.3K | 33 | 31 |
| West Virginia | $3.1K | 32 | 19 |
| Alaska | $2.9K | 29 | 25 |
| South Dakota | $1.5K | 11 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.